Archive for the ‘KIDNEYS’ Category

Why Liver Cancer Numbers Continue to Increase

Tuesday, July 11th, 2017

The five-year survival rate for people with liver cancer remains at only 20 percent. Diabetes, hepatitis C, smoking, and alcohol are all factors.

Between 2009 and 2013, doctors diagnosed liver cancer in 7.7 people out of every 100,000.

That number has been increasing since the mid-1970s.

In addition, the death rate is rising faster than for any other cancer — it is one of America’s leading causes of cancer death.

Between 2010 and 2014, it stood at 6.3 people per 100,000.

The five-year survival rate is only about 20 percent.

Healthline spoke with Dr. Jack Jacoub, medical oncologist and director of thoracic oncology at MemorialCare Cancer Institute at Orange Coast Memorial Medical Center in California.

He stated that liver cancer is “the second most common cancer killer in the world.”

This month, researchers at the American Cancer Society (ACS) published a groundbreaking study in CA: A Cancer Journal for Clinicians.

During the study, researchers uncovered trends in liver cancer incidence, survival, and mortality rates.

Researchers used Surveillance, Epidemiology, and End Results (SEER) program data obtained from the National Center for Health Statistics.

Read more: Get the facts on liver cancer »

Risk factors

The following risk factors contribute to liver cancer:

Dr. Anton Bilchik, professor of surgery and chief of gastrointestinal research at John Wayne Cancer Institute at Providence Saint John’s Health Center in California, also spoke with Healthline.

Bilchik said “the reason for the increase in primary liver cancer is largely related to the obesity epidemic that we have going on in this country.”

“Whereas hepatitis C used to be the most common cause of liver cancer, the most common cause now is related to nonalcoholic fatty liver disease,” he noted.

Jacoub, meanwhile, believes that hepatitis still poses the greatest risk.

“There is a very big spiking in hepatitis C infection over the past few decades. And that is the predominant risk factor in the United States for liver cancer,” he said.

Jacoub also suggested another risk factor. He cautioned that “anyone who has hereditary iron overload symptoms,” such as hemochromatosis, is at risk.

“[This] iron scenario causes iron overloading of the liver and [that] causes inflammation and scarring and then … cirrhosis,” he said.

“Whenever cirrhosis develops, you’re immediately at risk for liver cancer,” Jacoub explained.

Read more: Symptoms and warning signs of hepatitis C »

The influx of hepatitis C

“The incidence of hepatitis C in the baby boomer population [those born between 1945 and 1965] is as high as 2 to 3 percent,” reported Bilchik. “And it’s been recommended that all baby boomers should be at least checked for hepatitis C, particularly since recently we [now] have drugs that are very effective at curing patients of hepatitis C.”

Bilchik added, “The biggest breakthrough in this field has been the fact that relatively nontoxic antiviral medications are now FDA-approved that can eradicate hepatitis C.”

“The problem,” he said, “is that a very small percentage of baby boomers are being tested, or have been tested.”

Hepatitis B infection is also preventable. And there is an effective vaccine.

Starting in 1982, hepatitis B vaccinations became a part of routine childhood vaccinations.

As a result, in 2015 the vaccination rate among younger people varied from a low of 83 percent in Idaho, to a high of 98 percent in New Hampshire.

However, only 50 percent of older adults in the United States have been vaccinated.

Read more: Western diets are causing obesity in people around the world »

The risk associated with weight

Studies show that liver cancer risk increases by 26 percent for every five point increase in one’s Body Mass Index (BMI).

More men than women are overweight (BMI 25.0-29.9.) However, a greater number of women fall into the categories of obese (BMI 30-39.9), and class 3 obese (BMI 40+).

Bilchik noted, “Non-insulin dependent diabetes and lack of physical activity are often associated and linked to obesity.”

In the United States, 69 percent of adults over age 20 are overweight.

“It’s well known that up to 25 percent of kids, if not more, are overweight, if not obese,” stated Bilchik.


Indications are that greater weight control intervention can help, especially among children.

Interventions might help reduce obesity levels, type 2 diabetes, and ultimately liver cancer rates.

Read more: Get the facts on alcohol addiction »

Alcohol, tobacco risk factors

Regardless of amount, drinking alcohol increases your risk of liver cancer.

“Not just in alcoholics,” Bilchik noted, “but also in those people that are considered binge drinkers.”

More effort put into alcohol abuse prevention programs may prove beneficial.

Smokers have a higher risk for liver cancer, too.

Tobacco users increase their risk of liver cancer by approximately 50 percent.

Read more: Poverty linked to poor health »

Race, ethnicity make a difference

There are now treatments for hepatitis C, vaccines for hepatitis B, and better public education about the risks of obesity.

As such, one might expect liver cancer rates to be falling.

But they’re not.

Until the publication of the ACS study, it was difficult to find information that explored total liver cancer mortality and survival rates in the United States.

This was also true for liver cancer mortality and survival rates with regard to race and ethnicity.

Regarding the study, Jacoub noted “liver cancer is one of the few cancers that really has extremely dramatic ethnic variations in population variations. And you’re seeing it in this report.”

The researchers found that the death rate for liver cancer in non-Hispanic whites was 5.5 per 100,000 people.

That compared with 8.4 per 100,000 for blacks, 11.9 per 100,000 for American Indians/Alaska Natives, 9.8 per 100,000 for Asian/Pacific Islanders, and 9.1 per 100,000 for Hispanics.

Digging deeper, the analysis showed that liver cancer incidence varies from state to state, and by race and ethnicity within each state.

Much of the disparity is due to a lack of public health education for certain at-risk groups.

Many of these same populations often also have limited access to quality healthcare.

Read more: Are there early signs of kidney cancer? »

Catching cancer early

The five-year survival rate after a diagnosis of liver cancer has been increasing ever since the early 1990s.

The increase, however, varies among racial and ethnic groups.

Generally, non-Hispanic whites have a lower death rate from liver cancer than blacks.

One of the reasons is that non-Hispanic whites are more likely to undergo surgery for their cancer.

Blacks as a group are more likely to lack health insurance, which may cause people to delay testing.

The stage of liver cancer at the time of diagnosis influences the survival rate.

Between 2006 and 2012, people with localized cancers accounted for between 40 and 45 percent of all liver cancer diagnoses. These patients had a survival rate of 37 percent.

That rate dropped to 4 percent for distant stage cancer diagnoses.

When researchers factored race and ethnicity into their analysis of localized disease, they saw a marked difference in survival rates.

It is possible to narrow the gap in survival rates between ethnic and racial groups?

Researchers believe the key is in finding ways to diagnose more liver cancers when they are still in the early, more localized stages.

Read more: Baby boomers changing the healthcare landscape »

Over the hump by 2030?

Death rates are expected to continue rising through 2030, and then begin to fall. Bilchik and Jacoub suggested a few possible reasons for the decline.

Baby boomers are currently the most at-risk generation for hepatitis C. Their numbers will continue to shrink as time passes.

In the meantime, more effective public health education will increase the number of baby boomers who seek out testing for hepatitis C.

Also, public education efforts worldwide should increase the number of people receiving hepatitis B vaccinations.

In time, the costs of treating hepatitis C will decline.

Fast food restaurants will continue the current trend of offering foods that are more nutritious

The number of tobacco smokers should continue to decline.

Jacoub stressed, “It’s important to know your risk profile.”

And Bilchik pointed out, “If you think about it, primary liver cancer is largely preventable because most of the causes of liver cancer are related to lifestyle.”

Henry Sapiecha


Saturday, November 27th, 2010

Pomegranate Juice:

How it helps kidney dialysis patients

from complications

A recent study has shown that pomegranate juice helps protect dialysis patients from infections, inflammation and tissue damage.

A good number of studies conducted in recent years have professed support to the wide range of health benefits brought about by the intake of pomegranate juice.  It is said to contain excellent amounts of antioxidants which helps boost a person’s immune system.  Also, pomegranate juice have shown potential effects in lowering bad cholesterol levels and blood pressure – very important effects especially for people diagnosed with diabetes and hypertension.

Aside from the mentioned health benefits, the results of a preliminary study have suggested that pomegranate juice can help protect the body against some complications of undergoing dialysis due to kidney disease, which includes the high death rate due to cardiovascular events and infections.  This is according to a paper presented at the 43rd Annual Meeting and Scientific Exposition of the American Society of Nephrology held in Denver, Colorado.

Effect on Patients under Dialysis

101 patients undergoing dialysis were enrolled in the study.  They were then divided into two groups: one group received pomegranate juice prior to every dialysis session, and another group received a placebo drink, thrice a week for a period of one year.  They were observed by Lilach Shema, a PhD candidate, Dr. Batya Kristal, FASN, (Western Galilee Hospital in Nahariya, Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology in Haifa, Israel) and colleagues.

Results of the laboratory tests revealed that patients who consumed pomegranate juice exhibited reduction in inflammation and diminished oxidative stress damage caused by free radicals.  Furthermore, those who drank pomegranate juice had reduced risk of hospitalization brought about by infections. The findings of this recent study corroborate with the findings of previous studies saying that pomegranate juice contains powerful and effective antioxidant properties.

Pomegranate Juice also Good for the Heart

When data that was not included in the abstract was analyzed, it revealed that patients who consumed pomegranate juice also exhibited improved risk factors for cardiovascular conditions such as a reduction in blood pressure, improved lipid profile and lower cardiovascular events.  This suggests that the patients who drank pomegranate juice had better cardiovascular health compared to those who didn’t.  The said findings are in consonance with the other studied subjects, especially important for patients who are undergoing dialysis because a good number of patients with kidney disease die either from infections or cardiovascular-related causes.

The authors of the study said the their findings indicate that consuming pomegranate juice in controlled amounts coupled with a monitored and safe levels of potassium may help lessen complications that frequently occurs in patients undergoing dialysis.  It is very important to consider the involved risks in too much potassium content, most especially in patients with chronic kidney disease whose diets include potassium restriction.

Dr. Kristal said that more clinical trials should be conducted regarding the effects of pomegranate juice.  The study should be geared towards reducing the high morbidity rate related to cardiovascular events in patients with chronic kidney disease (CKD) and to put a stop to its deterioration to end-stage renal disease. The researchers said that the next decade may bring about an epidemic of CKD.

What is Chronic Kidney Disease?

Chronic kidney disease is a condition in which the kidney gradually, and permanently, loses its function. The kidneys are responsible for filtering the blood in order to get rid of excess water and waste products. Waste and water will convert into urine and will then be flushed out of the body. When the normal function of the kidneys is disrupted, waste products and excess water starts to accumulate.  This becomes toxic to the body which may affect various body parts.

The following conditions may cause chronic kidney disease:

  • Uncontrolled hypertension
  • Presence of kidney stones
  • Heroin abuse
  • Sickle Cell disease
  • HIV Infection
  • Atherosclerosis (hardening of the arteries)
  • Polycystic kidney disease
  • Glomerulonephritis
  • Diabetes Mellitus (Types 1 and 2)

The worst stage of chronic kidney disease is the Stage 5.  This stage is also referred to as end-stage renal disease or kidney failure.  What happens is that, there is a near-total or total loss of kidney function.  Toxic substances, waste products and excess water start to accumulate which may cause various signs and symptoms to the patient.  When this happens, kidney transplantation or dialysis is needed for the patient to stay alive.

Common signs and symptoms include:

  • Easy fatigability
  • Pruritus (generalized itching)
  • Dry skin
  • Nausea and Vomiting
  • Loss of Appetite
  • Unintentional weight loss
  • Headaches
  • Swelling of the extremities (hands and feet)
  • Problems in sleeping
  • Amenorrhea (absence of menstrual periods)
  • Excessive thirst
  • Easy bruising
  • Frequent muscle cramps and twitching
  • Confusion
  • Drowsiness

How to keep your kidneys healthy

  • Avoid eating foods that contain high amounts of salt.
  • Drink a lot of water.
  • Avoid too much alcohol intake
  • Visit your doctor for regular check-ups.
  • Eat a balanced diet.  Include vegetables and fruits that are rich in polyphenols.  Examples include carrot juice, dried fruits, cauliflower, sun dried tomatoes, avocados, asparagus, green beans, beetroot, mushrooms and potatoes.

Other Benefits of Pomegranate Juice

As mentioned, numerous studies have been conducted regarding the health benefits of pomegranate juice consumption.  Despite its benefits, pomegranate juice contains high amounts of sugar, so remember to drink moderately.

Other known benefits of pomegranate juice are:

  • In a study published in Journal of Agricultural and Food Chemistry, pomegranate juice helps reduce the risk of prostate cancer.
  • In the Clinical Nutrition journal, researchers said that drinking pomegranate juice boosts the quality of sperm in men.
  • Pomegranate juice helps stop the progression of Alzheimer’s disease.  This is the result of a study published in the Neurobiology of Disease journal.
  • Studies conducted in Israel have shown that pomegranate juice helps fight breast cancer.  It destroys the cancer cells but leaves healthy cells unharmed.
  • Studies conducted with the use of mice have shown that drinking pomegranate juice may prevent lung cancer development.
  • For pregnant women, consumption of pomegranate juice helps protect the neonatal brain from damage.
  • Pomegranate juice is also good for the heart – it prevents the build up of fatty plaques in arteries which could cause heart attacks and stroke.
  • Sourced & published by Henry Sapiecha


Sunday, June 13th, 2010

No More Dialysis

Immunologists Develop Method

To Decrease Rejections

Of Kidney Transplants

A nephrologist has found that a specialized type of anti-rejection therapy using intravenous immunoglobulin can make kidney transplants possible for patients with high ‘anti-donor’ antibodies. 25 to 30 percent of patients on the kidney transplant list could benefit from this therapy. Tissue compatibility issues exist with any organ transplant, but the risk is greatly increased for those with high exposure to antigens received through blood transfusions, previous transplantation, or even pregnancy.

Seventy-thousand Americans are waiting for a kidney transplant. A third of them are parked on dialysis because their antibody levels are too high for a transplant. But that’s no longer a barrier for some people.

“I used to just sit around and throw up,” says former dialysis patient Soraya Kohanzadeh.

Dialysis is something Kohanzadeh would rather forget, but if telling her story saves lives, it’s worth it.

Kohanzadeh — like many kidney failure patients — developed high levels of “anti-donor” antibodies through blood transfusions. Her highly sensitized immune system would likely reject any donated kidney.

“Essentially, she would have a very short, sick life on dialysis,” says Joan Lando, Kohanzadeh’s mother.

But Kohanzadeh is no longer here, thanks to intravenous immunoglobulin therapy or IVIG. Here’s how it works: during dialysis, patients are given blood containing a mix of immunoglobulins, which “turn-off” the anti-donor antibodies’ attack response without suppressing the patient’s immune system.

“A significant other comes forward, donates an organ, and there’s an incompatibility there. We can treat the patient and remove those antibodies. Then the transplant can be done,” Stanley Jordan, M.D., director of nephrology at Cedars-Sinai Medical Center in Los Angeles.

More than a year after surgery, Lando’s kidney keeps her daughter alive.

“It was sort of shocking to think I wasn’t going to have to be sick forever,” Kohanzadeh says.

Through their website, this mother-daughter team works to spread the word of a little known therapy that could save thousands in need of a kidney. IVIG is covered by Medicare and can be used in both living and cadaver-donor transplants. Nearly 30 percent of patients on the kidney transplant list might benefit from this therapy.

To learn more go to

BACKGROUND: About one-third of kidney patients are often told they cannot have a transplant even if they have a donor with an otherwise perfectly matched tissue and blood type. Their anti-donor antibody levels are so high that any transplanted organ would be rejected by their highly sensitized immune system. Now there is a specialized type of anti-rejection therapy using intravenous immunoglobin (IVIG), which injects antibodies from healthy people into the blood supply, to modulate the immune system without suppressing it. This makes kidney transplant possible for as much as 25-30% of this group of patients, who would otherwise not be eligible for a transplant because of their high antibody levels.

DEALING WITH REJECTION: Tissue compatibility is an issue for all patients receiving organ transplants, but rejection risks are much higher for those with high exposure to human leukocyte antigens (HLAs) that are not produced by their own bodies. Exposure may be the result of blood transfusions, previous transplantation, or even pregnancy if the mother is exposed to the father’s antigens, which are then expressed in the cells of the developing fetus. The immune system is then ‘sensitized’ to those antigens — primed with antibodies that attack any foreign tissue, even if the antigens arrive in the form of a life-saving donated organ.

ABOUT IVIG: IVIG modulates the immune system without suppressing it. In fact, the therapy actually boosts the immune system because the antibodies found in IVIG help fend off infections — a common post-surgery complication. For the most highly sensitized patients, IVIG is combined with a new drug, Rituxan, which reduces treatment time from four months to one before transplantation. The therapy can be used in both living-donor and cadaver-donor transplants. In the late 1980s. Dr. Stanley C. Jordan pioneered the use of IVIG as a way to reduce organ rejection among highly sensitized patients. It is now a fully accepted, Medicare-approved therapy as of 2004, when it was found to be effective in a multi-center study partly funded by the National Institutes of Health.

WHAT IS DIALYSIS? Hemodialysis is a treatment for end stage renal disease (ESRD), or kidney failure, in which blood is removed from the body, filtered through an artificial kidney and then the cleaned blood is returned to the body. In the US, hemodialysis is the most common treatment for people who have kidney failure. However, dialysis is also a painful, expensive procedure, and while it cleans the blood well enough to maintain existence, it does little to improve a patient’s overall quality of life. Also, data shows that if patients get a transplant before they get to the point of dialysis, they do better in the longer term.

Sourced and published by Henry Sapiecha 12th June 2010


Tuesday, September 8th, 2009

A New Way To Nix Pain

By Michael Roizen, M.D., and Mehmet Oz, M.D.

The Rolling Stones changed lives. So do kidney stones. Both can make you keel over like a rugby player who’s been kneed in the groin (for different reasons). Traditionally, keeping stones at bay (kidney stones, not the Rolling Stones) meant treating your body like an empty swimming pool and flooding it with water to flush it out.

That’s still a good idea. But now, there’s also evidence that a little addition and subtraction can dramatically reduce your risk for the stones that create intense pain (and we mean intense) in your lower back and side when you urinate:

What to add: Vegetables, nuts, legumes, nonfat dairy products and 100 percent whole grains. Pile ’em on.
What to subtract: Sodium, sweetened beverages, and red and processed meats.
What it gets you: People who ate this way had a gigantic 40 percent to 45 percent reduction in kidney-stone risk (men saw the higher drop in risk).

Even niftier about this whole equation (even if you don’t like math) is that the diet the stone-free people were eating was similar to the DASH diet.

That simple diet has been shown to lower blood pressure — a major health boost, since high blood pressure will be responsible for more than 60,000 deaths this year in the U.S. alone.

The diet is also rich in nutrients the rest of your body loves for other reasons, and low in the stuff that treats your body the way pigeons do a statue. So add a little, subtract a little and reap the rewards.

Sourced and published by Henry Sapiecha 8th Sept 2009



Sunday, June 28th, 2009



One million Americans suffer heart attacks every year. Quickly getting their arteries propped open with stents saves lives, studies have found. But millions more develop heart symptoms gradually. Usually it comes in the form of angina, a squeezing pain in the chest or arms caused by clogged arteries that starve the heart muscle of oxygen. The pain comes with exercise or stress, and then goes away.

People often assume they need a stent to get that artery opened up right away–or else. But new results from two big trials are unambiguous: The high-tech procedures don’t save lives or prevent heart attacks for most patients with stable symptoms. “It doesn’t do anything to lower risk of subsequent death or heart attack,” says William Boden, a cardiologist at the State University of New York at Buffalo who led one of the trials. Drug treatment alone is just as effective.

The reason for this counterintuitive result is that most heart attacks don’t occur at the locations that appear most clogged on an angiogram. Instead, heart attacks happen when lesser narrowings become inflamed and suddenly rupture, spewing a clot into the bloodstream. The blockage that bursts isn’t necessarily the one that causes symptoms. People think heart disease “is just a plumbing issue, that clogged pipes mean an impending heart attack,” says James Stein of the University of Wisconsin at Madison. “A stent is just a local therapy for a systemic problem.”

Stents are installed during angioplasty, in which a balloon is used to unclog an artery. They are necessary if drugs cannot produce enough pain relief, say cardiologists. One of the two trials found that 66 out of 100 patients who received a stent were angina free after a year versus 58 out of 100 who received only drugs; that difference faded after five years.

Another study published in June comparing stents to drugs in diabetic heart patients found no difference in the risk of death or heart attacks, and only a little over 40% of those assigned drugs later got a stent. A more clogged-up group received either drugs or cardiac bypass surgery, in which veins are used to bypass blocked arteries. The bypass patients didn’t live longer but did have fewer nonfatal heart attacks. “I think physicians will be more likely to consider bypass for their diabetic patients and steer away from angioplasty,” says study author Sheryl Kelsey of the University of Pittsburgh.

One diabetic patient who did well without a stent is Earl Anderson of Old Bridge, N.J. The 62-year-old retired FBI agent first felt chest pains while rushing to catch a plane in 2002. An angiogram revealed a narrowing in one artery, and doctors gave him drugs. His angina soon went away and hasn’t come back. Now his cholesterol and blood sugar are down; he plays tennis weekly with his 14-year-old son


Your Heart: A User’s Guide

Cardiologists who install stents say that these relieve pain better than drugs and that most patients have more symptoms than Anderson. “Patients with a lot of symptoms don’t do well with drug therapy,” says Gregg Stone of New York-Presbyterian Hospital.

One reason so many stents are implanted is money. “Hospitals are paid handsomely if the patient has bypass surgery or has a stent. But they are not paid [so much] if a patient has drugs,” says cardiologist David Hillis of the UT Health Science Center in San Antonio. While generally safe, stent procedures can cause heart attacks, bleeding or even death.

Another misconception is that getting a procedure will obviate the need for drugs. “People have this impression that ‘If I get a stent, then I am not going to have to take medicine,’ and that is wrong,” says Mayo Clinic cardiologist Raymond Gibbons. “Everybody is going to get medicines. The real question: Is stenting or surgery going to bring enough benefit in addition?” Patients who get drug-coated stents often must take more drugs; they need to stay on the blood thinner Plavix for at least a year to prevent rare cases of clots forming in the stent.

One key test that is often skipped: stress tests to determine if your heart is getting enough oxygen during exercise. The problem, says Scripps Research Institute cardiologist Eric Topol: Without stress tests, doctors don’t know whether narrowings seen on an angiogram are causing problems.

Heart patients with stable symptoms have choices–and time to consider their decisions. For many of them drug therapy alone, drug therapy and stents, or drug therapy with angioplasty are all reasonable options. If you are not sure which you want, you can ask the doctor doing your angiogram to hold off on the stent if nothing alarming is found. This will give you time to discuss the result with your primary care doctor or referring cardiologist.

A lack of blood flow to the heart causes chest discomfort but doesn’t kill the muscle. Most angina comes on only during exertion and stops afterward. Unstable angina that happens at rest is treated as a medical emergency.

Eat a healthy diet and exercise to prevent the buildup of artery plaque.

Take statins and blood pressure drugs if your doctor dictates.

For most patients, drug therapy can reduce the risk of heart attack and treat chest pain.

A stent/angioplasty procedure can reduce chest pain but has no proved impact on survival in those with stable symptoms.

Sourced and published by Henry Sapiecha 28th June 2009



Thursday, June 25th, 2009


Thursday, June 25th, 2009

New Research Uncovers Amazing Brain Saver!


Clogged arteries prevent blood supply to the brain. Oxygen-deprived brain cells become damaged or even die.

But when scientists induced strokes in laboratory rats and treated them with an amazingly simple nutrient—a remarkable discovery was made. Here’s what happened…

In one experiment, strokes were induced in laboratory rats by blocking the carotid artery for 30 minutes. Once blood flow and oxygen were restored, there was a burst in the production of free radicals. This overwhelmed the brain’s antioxidant defenses and killed 80% of the rats within 24 hours.

In a follow-up experiment, everything was the same, except this time, researchers injected a powerful antioxidant into the rats before blood and oxygen was restored. After a 24 hour period—only 25% of the rats died. The remaining 75% made a full recovery. Further study concluded the brain of the antioxidant-treated rats showed no signs of a stroke at all!

The name of this stellar brain saver?
It’s alpha lipoic acid!

This research and many more demonstrate alpha lipoic acid can deliver remarkable protection to your brain to help prevent damage—and even help restore healthy brain function in the event of a blockage of blood flow to the brain.

That’s why you get the optimum dosage of alpha lipoic acid in every serving of Advanced Artery Solution™. It’s the ultimate insurance for brain health!

Try Advanced Artery Solution™ Risk-Free Today…
It’s Guaranteed to Work
or it’s FREE!

Plus Claim up to $502.65 in
Savings and Free Gifts Now

Can’t order online?

Call toll-free

To receive this special web only offer, please reference savings code: TEC1434

Sourced and published by Henry Sapiecha 25th June 2009



Thursday, June 25th, 2009

Malic Acid—the critical partner of the EDTA chelation Dynamic Duo!


Studies have shown that EDTA is highly effective at removing most heavy metals from your body. But for optimal chelation therapy—getting rid of most of the toxic metals is just not good enough. That’s why Advanced Artery Solution™ also gives you optimum doses of malic acid—a powerful, complementary chelator that picks up where EDTA leaves off!

With malic acid, you can remove dangerous aluminum from your blood. Research shows aluminum can cause memory loss, brain decay and even unexplainable fatigue.

In one clinical test, fibromyalgia patients were given malic acid along with magnesium for eight weeks. All the patients reported significant reduction of muscular pain within 48 hours of starting the supplement!

For the #1 source of in-home, oral chelation—there’s nothing better than Advanced Artery Solution™! Now you can sample this heart supporting nutrient completely RISK FREE during this special introductory offer.

Source: EDTA Chelation, The Real Miracle Therapy
for Vascalur Disease. Life Enhancement, 2006.

Try Advanced Artery Solution™ Risk-Free Today…
It’s Guaranteed to Work
or it’s FREE!

Plus Claim up to $502.65 in
Savings and Free Gifts Now

Can’t order online?

Call toll-free

To receive this special web only offer, please reference savings code: TEC1434

Sourced and published by Henry Sapiecha 25th June 2009